2017
DOI: 10.5301/ijao.5000657
|View full text |Cite
|
Sign up to set email alerts
|

Fluid structure interaction model analysis of cerebrospinal fluid circulation in patients with continuous-flow left ventricular assist devices

Abstract: The existing FSI model is not a suitable representation of CSF flow in CF-LVAD patients. More studies are needed to elucidate the role of pulsatility in CSF flow and the compensatory changes in CSF production and absorption that occur in patients with CF-LVADs in whom pulsatility is diminished.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…The results of this hypothesis remain unclear as CSF flow models in LVAD patients have not been successful to date [ 3 ]. One study using a computational model demonstrated that continuous flow resulted in a reduction in CSF pressure amplitude and velocity though the overall flow rate was unchanged [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The results of this hypothesis remain unclear as CSF flow models in LVAD patients have not been successful to date [ 3 ]. One study using a computational model demonstrated that continuous flow resulted in a reduction in CSF pressure amplitude and velocity though the overall flow rate was unchanged [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, it has been postulated that the altered circulatory physiology in LVAD patients could alter cerebrospinal fluid (CSF) flow given the lack of traditional pulsatile blood pressure [ 3 ]. The efficacy of CT myelograms has thus been questioned in these patients, increasing the level of diagnostic complexity in already inherently difficult cases.…”
Section: Introductionmentioning
confidence: 99%
“…In patients with end-stage heart failure refractory to maximum medical therapy, treatment options include heart transplantation, mechanical circulatory support, or palliative care. [4][5][6][7] Potentially life-saving transplants, the current standard of care, are limited by a lack of donors. Thousands are registered awaiting a donor heart; 40% of those who are on the waiting list die.…”
Section: Introductionmentioning
confidence: 99%
“…Progression of this disease is slowed by the use of cardiac drug therapy to mitigate symptoms of the disease. In patients with end‐stage heart failure refractory to maximum medical therapy, treatment options include heart transplantation, mechanical circulatory support, or palliative care . Potentially life‐saving transplants, the current standard of care, are limited by a lack of donors.…”
Section: Introductionmentioning
confidence: 99%
“…However, none of these milestones has been achieved yet. From this particular standpoint, his research interests include cerebrospinal fluid circulation in LVAD patients with diminished or absent pulse, algorithms for full adjustability of continuous flow, energy sources allowing full device implantability (among others, Plutonium 238), and development of biohybrid and bioartificial organs . He has worked as a research fellow at Bern University Hospital in Bern, Switzerland, Medical University of Innsbruck in Innsbruck, Austria, and Brigham and Women's Hospital in Boston, MA, USA studying various stem cells types for myocardial recovery .…”
mentioning
confidence: 99%